Gates Foundation Awards $1 Million for HIV Prevention Initiative

The new initiative comes at a time when researchers developing new HIV prevention technologies like Pre-Exposure Prophylaxis (PrEP) and rectal microbicides are anticipating the results of important efficacy trials. Should these technologies prove to be effective, they would become part of a growing body of evidence-based prevention tools targeting MSM. The urgency of implementing these tools effectively is clearer than ever, with MSM now shown to be 19 times more likely to be infected with HIV than the general population in low- and middle-income countries.